Mueller indicts 13 Russian nationals for interfering in the 2016 election


Special Counsel Robert Mueller's team has indicted 13 Russian nationals and three Russian entities for meddling in the 2016 election. In the first election interference charges to result from Mueller's probe, the federal indictment states that the defendants "conspired to obstruct the lawful functions of the United States government through fraud and deceit."
The document explains how a Russian organization, the Internet Research Agency, used fake accounts on various social media platforms to sow chaos during the presidential election. In some cases, Russian agents assumed the identities of real Americans to manipulate social media. The goal was to "use any opportunity to criticize Hillary [Clinton] and the rest" of the candidates, while actively supporting Sen. Bernie Sanders (I-Vt.) and Donald Trump. The Russians also allegedly aimed to suppress the minority vote by encouraging minorities to vote for a third-party candidate or skip voting altogether.
The indictment also claims that "unwitting members, volunteers, and supporters of the Trump campaign" came into contact with Russians posing as Americans. In a press conference announcing the indictment, Deputy Attorney General Rod Rosenstein said the charges were "a reminder that people are not always who they seem on the internet." Still, he told reporters, "There is no allegation in this indictment that [such meddling] altered the outcome of the 2016 election."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Read the indictment in full here.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.
-
Jeffrey Epstein's secrets
Feature Six years after his death, conspiracy theories still swirl around the sex trafficker. Why?
-
Voting: Trump's ominous war on mail ballots
Feature Donald Trump wants to sign an executive order banning mail-in ballots for the 2026 midterms
-
School phone bans: Why they're spreading
Feature 17 states are imposing all-day phone bans in schools
-
South Korea to fetch workers detained in Georgia raid
Speed Read More than 300 South Korean workers detained in an immigration raid at a Hyundai plant will be released
-
DC sues Trump to end Guard 'occupation'
Speed Read D.C. Attorney General Brian Schwalb argues that the unsolicited military presence violates the law
-
RFK Jr. faces bipartisan heat in Senate hearing
Speed Read The health secretary defended his leadership amid CDC turmoil and deflected questions about the restricted availability of vaccines
-
White House defends boat strike as legal doubts mount
Speed Read Experts say there was no legal justification for killing 11 alleged drug-traffickers
-
Epstein accusers urge full file release, hint at own list
speed read A rally was organized by Reps. Ro Khanna and Thomas Massie, who are hoping to force a vote on their Epstein Files Transparency Act
-
Court hands Harvard a win in Trump funding battle
Speed Read The Trump administration was ordered to restore Harvard's $2 billion in research grants
-
Florida aims to end all state vaccine requirements
Speed Read Health Secretary Robert F. Kennedy Jr. continues to cut vaccine access and install anti-vaccine activists at the FDA and CDC
-
US kills 11 on 'drug-carrying boat' off Venezuela
Speed Read Trump claimed those killed in the strike were 'positively identified Tren de Aragua Narcoterrorists' shipping drugs to the US